Theravance Biopharma Inc (TBPH)
9.17
-0.05
(-0.54%)
USD |
NASDAQ |
Apr 24, 16:00
9.165
0.00 (0.00%)
After-Hours: 20:00
Theravance Biopharma Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | -1.786 |
| March 31, 2022 | -1.768 |
| December 31, 2021 | -1.820 |
| September 30, 2021 | -1.903 |
| June 30, 2021 | -2.029 |
| March 31, 2021 | -1.645 |
| December 31, 2020 | -2.038 |
| September 30, 2020 | -2.337 |
| June 30, 2020 | -2.974 |
| March 31, 2020 | -3.799 |
| December 31, 2019 | -2.033 |
| September 30, 2019 | -2.496 |
| June 30, 2019 | -3.319 |
| March 31, 2019 | -4.016 |
| December 31, 2018 | -8.807 |
| Date | Value |
|---|---|
| September 30, 2018 | -16.70 |
| June 30, 2018 | 6.522 |
| March 31, 2018 | 3.533 |
| December 31, 2017 | 1.943 |
| September 30, 2017 | 1.214 |
| June 30, 2017 | 0.9257 |
| March 31, 2017 | 0.7584 |
| December 31, 2016 | 0.6358 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-3.799
Minimum
Mar 2020
--
Maximum
Sep 2022
-1.576
Average
-1.820
Median
Dec 2021
Debt to Equity Ratio Benchmarks
| Corcept Therapeutics Inc | 0.00 |
| Nektar Therapeutics | 0.00 |
| Vanda Pharmaceuticals Inc | 0.00 |
| Fate Therapeutics Inc | 0.00 |
| FibroGen Inc | -0.3523 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 382.00M |
| Total Liabilities (Quarterly) | 169.00M |
| Shareholders Equity (Quarterly) | 213.00M |
| Current Ratio | 5.392 |